documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
61 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-N-0011-0028 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | Final Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-03-04T04:59:59Z | 2025-03-05T02:00:44Z | 2024-31419 | 0 | 0 | 0900006486896c8a |
| FDA-2016-D-2335-1702 | FDA | FDA-2016-D-2335 | Food Labeling: Nutrient Content Claims; Definition of Term "Healthy" | Rule | Final Rule | 2024-12-27T05:00:00Z | 2024 | 12 | 2024-12-27T05:00:00Z | 2024-12-27T16:48:15Z | 2024-29957 | 0 | 0 | 0900006486891538 | |
| FDA-2021-N-0862-0207 | FDA | FDA-2021-N-0862 | Nonprescription Drug Product With an Additional Condition for Nonprescription Use | Rule | Final Rule | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T05:00:00Z | 2024-12-26T15:41:32Z | 2024-30261 | 0 | 0 | 090000648688bfbc | |
| FDA-2024-N-0002-0003 | FDA | FDA-2024-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor | Rule | Final Rule | 2024-12-02T05:00:00Z | 2024 | 12 | 2024-12-02T05:00:00Z | 2024-12-02T15:06:52Z | 2024-28061 | 0 | 0 | 0900006486843dce | |
| FDA-2022-N-1635-0018 | FDA | FDA-2022-N-1635 | Color Additive Certification; Increase in Fees for Certification Services | Rule | Final Rule | 2024-11-08T05:00:00Z | 2024 | 11 | 2024-11-08T13:57:22Z | 2024-25974 | 0 | 0 | 09000064868092dc | ||
| FDA-2018-F-3757-0019 | FDA | FDA-2018-F-3757 | Indirect Food Additives: Adhesives and Components of Coatings; Paper and Paperboard Components; Polymers; Adjuvants, Production Aids, and Sanitizers | Rule | Final Rule | 2024-10-30T04:00:00Z | 2024 | 10 | 2024-10-30T04:00:00Z | 2024-10-30T14:32:52Z | 2024-25122 | 0 | 0 | 09000064867ebe98 | |
| FDA-2024-N-0002-0002 | FDA | FDA-2024-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address | Rule | Final Rule | 2024-10-28T04:00:00Z | 2024 | 10 | 2024-10-28T12:53:21Z | 2024-24820 | 0 | 0 | 09000064867e8d3a | ||
| FDA-2024-D-2977-0497 | FDA | FDA-2024-D-2977 | Food and Drug Administration Enforcement Policy for Association of American Feed Control Officials— Defined Animal Feed Ingredients; Guidance for Industry; Availability | Rule | Final Rule | 2024-10-24T04:00:00Z | 2024 | 10 | 2024-10-24T04:00:00Z | 2024-10-24T12:58:03Z | 2024-24715 | 0 | 0 | 09000064867e1162 | |
| FDA-2024-N-3654-0005 | FDA | FDA-2024-N-3654 | Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments; Correction | Rule | Correction | 2024-10-18T04:00:00Z | 2024 | 10 | 2024-10-18T04:00:00Z | 2024-10-18T14:21:24Z | 2024-24100 | 0 | 0 | 09000064867d6c0e | |
| FDA-2021-N-0507-0087 | FDA | FDA-2021-N-0507 | Medical Devices; Quality System Regulation Amendments; Correction | Rule | Correction | 2024-10-15T04:00:00Z | 2024 | 10 | 2024-10-15T14:24:08Z | 2024-23701 | 0 | 0 | 09000064867ce682 | ||
| FDA-2016-N-2880-0007 | FDA | FDA-2016-N-2880 | Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management | Rule | Final Rule | 2024-09-23T04:00:00Z | 2024 | 9 | 2024-09-23T04:00:00Z | 2024-09-23T14:03:50Z | 2024-21616 | 0 | 0 | 090000648676a027 | |
| FDA-2024-N-3654-0002 | FDA | FDA-2024-N-3654 | Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments | Rule | Direct Final Rule | 2024-09-20T04:00:00Z | 2024 | 9 | 2024-09-20T04:00:00Z | 2024-12-05T04:59:59Z | 2024-12-06T02:01:03Z | 2024-21231 | 0 | 0 | 090000648675ecd8 |
| FDA-2024-N-4084-0001 | FDA | FDA-2024-N-4084 | Medical Devices; Immunology and Microbiology Devices; Classification of the Quantitative Viral Nucleic Acid Test for Transplant Patient Management | Rule | Final Rule | 2024-09-17T04:00:00Z | 2024 | 9 | 2024-09-17T04:00:00Z | 2024-09-17T14:02:07Z | 2024-21086 | 0 | 0 | 090000648672f697 | |
| FDA-2024-N-4082-0001 | FDA | FDA-2024-N-4082 | Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System | Rule | Final Rule | 2024-09-16T04:00:00Z | 2024 | 9 | 2024-09-16T14:27:25Z | 2024-20999 | 0 | 0 | 0900006486722c9c | ||
| FDA-2024-N-4061-0001 | FDA | FDA-2024-N-4061 | Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers | Rule | Final Rule | 2024-09-16T04:00:00Z | 2024 | 9 | 2024-09-16T14:36:22Z | 2024-20896 | 0 | 0 | 0900006486722d0c | ||
| FDA-2024-N-4058-0001 | FDA | FDA-2024-N-4058 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System | Rule | Final Rule | 2024-09-16T04:00:00Z | 2024 | 9 | 2024-09-16T14:51:24Z | 2024-20895 | 0 | 0 | 0900006486722dad | ||
| FDA-2024-N-4018-0001 | FDA | FDA-2024-N-4018 | Medical Devices; Immunology and Microbiology Devices; Classification of the Whole Exome Sequencing Constituent Device | Rule | Final Rule | 2024-09-11T04:00:00Z | 2024 | 9 | 2024-09-11T13:13:44Z | 2024-20550 | 0 | 0 | 09000064866e9441 | ||
| FDA-2024-N-4059-0001 | FDA | FDA-2024-N-4059 | Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Pancreatic Debridement Device | Rule | Final Rule | 2024-09-09T04:00:00Z | 2024 | 9 | 2024-09-09T04:00:00Z | 2024-09-09T13:17:51Z | 2024-20248 | 0 | 0 | 09000064866cf75f | |
| FDA-2024-N-4086-0001 | FDA | FDA-2024-N-4086 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Blood Collection Device for Cell-Free Nucleic Acids | Rule | Final Rule | 2024-09-09T04:00:00Z | 2024 | 9 | 2024-09-09T04:00:00Z | 2024-09-09T13:20:12Z | 2024-20254 | 0 | 0 | 09000064866cf859 | |
| FDA-2024-N-3972-0001 | FDA | FDA-2024-N-3972 | Medical Devices; Gastroenterology-Urology Devices; Classification of the Hemodialyzer With Expanded Solute Removal Profile | Rule | Final Rule | 2024-09-06T04:00:00Z | 2024 | 9 | 2024-09-06T04:00:00Z | 2024-09-06T14:54:33Z | 2024-20081 | 0 | 0 | 09000064866caec3 | |
| FDA-2024-N-3947-0001 | FDA | FDA-2024-N-3947 | Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Open Loop Fluid Therapy Recommender | Rule | Final Rule | 2024-09-05T04:00:00Z | 2024 | 9 | 2024-09-05T04:00:00Z | 2024-09-05T13:16:15Z | 2024-19736 | 0 | 0 | 09000064866c2b4a | |
| FDA-2024-N-3973-0001 | FDA | FDA-2024-N-3973 | Medical Devices; Dental Devices; Classification of the Radiofrequency Toothbrush | Rule | Final Rule | 2024-09-05T04:00:00Z | 2024 | 9 | 2024-09-05T04:00:00Z | 2024-09-05T13:01:42Z | 2024-19868 | 0 | 0 | 09000064866c29dc | |
| FDA-2024-N-3971-0001 | FDA | FDA-2024-N-3971 | Medical Devices; Hematology and Pathology Devices; Classification of the Heparin and Direct Oral Factor Xa Inhibitor Drug Test System | Rule | Final Rule | 2024-09-05T04:00:00Z | 2024 | 9 | 2024-09-05T04:00:00Z | 2024-09-05T13:05:27Z | 2024-19824 | 0 | 0 | 09000064866c29e1 | |
| FDA-2024-F-3882-0001 | FDA | FDA-2024-F-3882 | Food Additives Permitted in Feed and Drinking Water of Animals; Pichia Pastoris Dried Yeast | Rule | Final Rule | 2024-09-05T04:00:00Z | 2024 | 9 | 2024-09-05T04:00:00Z | 2024-09-05T13:08:16Z | 2024-19856 | 0 | 0 | 09000064866c2a34 | |
| FDA-2024-N-3970-0001 | FDA | FDA-2024-N-3970 | Medical Devices; Ophthalmic Devices; Classification of the Hydrophilic Re-Coating Solution | Rule | Final Rule | 2024-09-05T04:00:00Z | 2024 | 9 | 2024-09-05T04:00:00Z | 2024-09-05T13:18:07Z | 2024-19882 | 0 | 0 | 09000064866c2bfe | |
| FDA-2024-N-3946-0001 | FDA | FDA-2024-N-3946 | Medical Devices; Physical Medicine Devices; Classification of the External Compression Device for Internal Jugular Vein Compression | Rule | Final Rule | 2024-09-03T04:00:00Z | 2024 | 9 | 2024-09-03T13:33:14Z | 2024-19722 | 0 | 0 | 09000064866bd020 | ||
| FDA-2024-N-3994-0001 | FDA | FDA-2024-N-3994 | Medical Devices; Orthopedic Devices; Classification of the Intervertebral Body Graft Containment Device | Rule | Final Rule | 2024-09-03T04:00:00Z | 2024 | 9 | 2024-09-03T13:36:32Z | 2024-19726 | 0 | 0 | 09000064866bd516 | ||
| FDA-2024-N-3992-0001 | FDA | FDA-2024-N-3992 | Medical Devices; Neurological Devices; Classification of the Digital Therapy Device for Attention Deficit Hyperactivity Disorder | Rule | Final Rule | 2024-09-03T04:00:00Z | 2024 | 9 | 2024-09-03T13:47:32Z | 2024-19720 | 0 | 0 | 09000064866bd62d | ||
| FDA-2024-N-3948-0001 | FDA | FDA-2024-N-3948 | Medical Devices; Dental Devices; Classification of the Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea | Rule | Final Rule | 2024-09-03T04:00:00Z | 2024 | 9 | 2024-09-03T13:42:08Z | 2024-19725 | 0 | 0 | 09000064866bd593 | ||
| FDA-2020-N-1395-0001 | FDA | FDA-2020-N-1395 | Prohibition of Sale of Tobacco Products to Persons Younger Than 21 Years of Age | Rule | Final Rule | 2024-08-30T04:00:00Z | 2024 | 8 | 2024-08-30T13:54:12Z | 2024-19481 | 0 | 0 | 09000064866b57e5 | ||
| FDA-2017-N-6730-0041 | FDA | FDA-2017-N-6730 | Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary Reporting for Manufacturers | Rule | Final Rule | 2024-08-29T04:00:00Z | 2024 | 8 | 2024-08-29T13:19:24Z | 2024-19414 | 0 | 0 | 09000064866b35bb | ||
| FDA-2024-F-3879-0001 | FDA | FDA-2024-F-3879 | Food Additives Permitted in Feed and Drinking Water of Animals; Fermented Ammoniated Condensed Whey | Rule | Final Rule | 2024-08-22T04:00:00Z | 2024 | 8 | 2024-08-22T04:00:00Z | 2024-08-22T13:41:12Z | 2024-18824 | 0 | 0 | 090000648665c3aa | |
| FDA-2024-N-3655-0001 | FDA | FDA-2024-N-3655 | Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Nucleic Acid Targets Including SARS–CoV–2 in Respiratory Specimens | Rule | Final Rule | 2024-08-16T04:00:00Z | 2024 | 8 | 2024-08-16T13:36:41Z | 2024-18266 | 0 | 0 | 090000648664db33 | ||
| FDA-2024-N-3356-0001 | FDA | FDA-2024-N-3356 | Medical Devices; General Hospital and Personal Use Devices; Classification of the Intravenous Catheter Force-Activated Separation Device | Rule | Final Rule | 2024-08-16T04:00:00Z | 2024 | 8 | 2024-08-16T13:41:42Z | 2024-18267 | 0 | 0 | 090000648664dbac | ||
| FDA-2024-N-3358-0001 | FDA | FDA-2024-N-3358 | Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Selected Microbial Agents That Cause Acute Febrile Illness | Rule | Final Rule | 2024-08-16T04:00:00Z | 2024 | 8 | 2024-08-16T13:44:20Z | 2024-18264 | 0 | 0 | 090000648664dc2e | ||
| FDA-2024-N-3008-0001 | FDA | FDA-2024-N-3008 | Advisory Committee; Allergenic Products Advisory Committee; Termination; Removal From List of Standing Committees | Rule | Final Rule | 2024-07-10T04:00:00Z | 2024 | 7 | 2024-07-10T12:33:47Z | 2024-15136 | 0 | 0 | 09000064865e4099 | ||
| FDA-2023-N-0937-0073 | FDA | FDA-2023-N-0937 | Revocation of Authorization for Use of Brominated Vegetable Oil in Food | Rule | Final Rule | 2024-07-03T04:00:00Z | 2024 | 7 | 2024-07-03T04:00:00Z | 2024-07-03T12:46:26Z | 2024-14300 | 0 | 0 | 09000064865d8a29 | |
| FDA-2024-N-2731-0001 | FDA | FDA-2024-N-2731 | Medicated Feed Mill License; Veterinary Feed Directive Drugs; Change of Address | Rule | Final Rule | 2024-06-21T04:00:00Z | 2024 | 6 | 2024-06-21T04:00:00Z | 2024-06-21T14:04:13Z | 2024-13678 | 0 | 0 | 09000064865c2b30 | |
| FDA-2021-N-1333-0025 | FDA | FDA-2021-N-1333 | Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases | Rule | Final Rule | 2024-06-18T04:00:00Z | 2024 | 6 | 2024-06-18T04:00:00Z | 2024-06-20T12:33:21Z | 2024-13190 | 0 | 0 | 09000064865bc84f | |
| FDA-2023-F-0147-0002 | FDA | FDA-2023-F-0147 | Food Additives Permitted in Feed and Drinking Water of Animals; Ethyl Cellulose | Rule | Final Rule | 2024-06-07T04:00:00Z | 2024 | 6 | 2024-06-07T04:00:00Z | 2024-07-09T03:59:59Z | 2024-07-09T01:00:55Z | 2024-12533 | 0 | 0 | 090000648659d9a1 |
| FDA-2019-N-3325-0170 | FDA | FDA-2019-N-3325 | Laboratory Accreditation for Analyses of Foods; Program Implementation; Determination of Sufficient Laboratory Capacity for Import-Related Food Testing Covered by the Regulation | Rule | Advance Notice of Proposed Rulemaking (ANPRM) | 2024-06-03T04:00:00Z | 2024 | 6 | 2024-06-03T14:01:40Z | 2024-12027 | 0 | 0 | 090000648659257d | ||
| FDA-2021-N-1348-0012 | FDA | FDA-2021-N-1348 | Administrative Destruction | Rule | Final Rule | 2024-05-31T04:00:00Z | 2024 | 5 | 2024-05-31T04:00:00Z | 2024-05-31T13:24:23Z | 2024-11564 | 0 | 0 | 090000648658e2ac | |
| FDA-2024-N-2357-0001 | FDA | FDA-2024-N-2357 | Advisory Committee; Science Advisory Board to the National Center for Toxicological Research; Termination; Removal From List of Standing Committees | Rule | Final Rule | 2024-05-30T04:00:00Z | 2024 | 5 | 2024-05-30T04:00:00Z | 2024-05-30T13:06:23Z | 2024-11811 | 0 | 0 | 090000648658c125 | |
| FDA-2018-N-3074-0006 | FDA | FDA-2018-N-3074 | Ophthalmic Devices; Reclassification of Ultrasound Cyclodestructive Device | Rule | Final Rule | 2024-05-20T04:00:00Z | 2024 | 5 | 2024-05-20T04:00:00Z | 2024-05-20T14:10:03Z | 2024-10895 | 0 | 0 | 0900006486572b9a | |
| FDA-2024-N-0002-0001 | FDA | FDA-2024-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address | Rule | Final Rule | 2024-05-15T04:00:00Z | 2024 | 5 | 2024-05-15T04:00:00Z | 2024-05-15T13:25:05Z | 2024-10586 | 0 | 0 | 0900006486566995 | |
| FDA-2006-N-0239-0021 | FDA | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species FDA-2006-N-0239 | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species | Rule | Final Rule | 2024-05-15T04:00:00Z | 2024 | 5 | 2024-05-15T04:00:00Z | 2024-05-15T13:29:02Z | 2024-10602 | 0 | 0 | 0900006486566a1a | |
| FDA-2023-N-2177-6849 | FDA | FDA-2023-N-2177 | Medical Devices; Laboratory Developed Tests | Rule | Final Rule | 2024-05-06T04:00:00Z | 2024 | 5 | 2024-05-06T04:00:00Z | 2024-05-06T15:21:51Z | 2024-08935 | 0 | 0 | 0900006486542654 | |
| FDA-2021-N-0471-0302 | FDA | FDA-2021-N-0471 | Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption Relating to Agricultural Water | Rule | Final Rule | 2024-05-06T04:00:00Z | 2024 | 5 | 2024-05-06T04:00:00Z | 2024-05-06T15:15:51Z | 2024-09153 | 0 | 0 | 0900006486542543 | |
| FDA-2024-F-1850-0001 | FDA | FDA-2024-F-1850 | Food Additives Permitted in Feed and Drinking Water of Animals; Condensed, Extracted Glutamic Acid Fermentation Product | Rule | Final Rule | 2024-04-29T04:00:00Z | 2024 | 4 | 2024-04-29T04:00:00Z | 2024-04-29T12:57:37Z | 2024-09073 | 0 | 0 | 09000064865215d3 | |
| FDA-2021-N-0403-0018 | FDA | FDA-2021-N-0403 | Food Additives: Food Contact Substance Notification That Is No Longer Effective | Rule | Final Rule | 2024-03-22T04:00:00Z | 2024 | 3 | 2024-03-22T04:00:00Z | 2024-03-22T15:13:03Z | 2024-05802 | 0 | 0 | 090000648648e6ba | |
| FDA-2020-N-1690-0064 | FDA | FDA-2020-N-1690 | Frozen Cherry Pie; Revocation of a Standard of Identity and a Standard of Quality | Rule | Final Rule | 2024-03-15T04:00:00Z | 2024 | 3 | 2024-03-15T04:00:00Z | 2024-03-15T14:15:53Z | 2024-04598 | 0 | 0 | 090000648647ceef | |
| FDA-2024-N-1052-0001 | FDA | FDA-2024-N-1052 | Medical Devices; Technical Amendments | Rule | Final Rule | 2024-03-15T04:00:00Z | 2024 | 3 | 2024-03-15T04:00:00Z | 2024-03-15T14:11:31Z | 2024-05473 | 0 | 0 | 090000648647cdad | |
| FDA-2024-N-0826-0001 | FDA | FDA-2024-N-0826 | Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Addition to List of Standing Committees | Rule | Final Rule | 2024-03-06T05:00:00Z | 2024 | 3 | 2024-03-06T05:00:00Z | 2024-03-06T14:30:03Z | 2024-04751 | 0 | 0 | 09000064864646b9 | |
| FDA-2023-N-0002-0032 | FDA | FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address | Rule | Final Rule | 2024-02-27T05:00:00Z | 2024 | 2 | 2024-02-27T05:00:00Z | 2024-02-27T14:10:51Z | 2024-03765 | 0 | 0 | 0900006486432bd9 | |
| FDA-2012-N-0920-0020 | FDA | FDA-2012-N-0920 | User Fees; Technical Amendment | Rule | Final Rule | 2024-02-26T05:00:00Z | 2024 | 2 | 2024-02-26T05:00:00Z | 2024-02-27T13:45:03Z | 2024-03777 | 0 | 0 | 090000648642e3b3 | |
| FDA-2024-N-0017-0001 | FDA | FDA-2024-N-0017 | Advisory Committee; Digital Health Advisory Committee; Addition to List of Standing Committees | Rule | Final Rule | 2024-02-22T05:00:00Z | 2024 | 2 | 2024-02-22T05:00:00Z | 2024-02-22T14:29:57Z | 2024-03618 | 0 | 0 | 09000064864250fc | |
| FDA-2019-N-1363-0029 | FDA | FDA-2019-N-1363 | Biologics License Applications and Master Files | Rule | Final Rule | 2024-02-12T05:00:00Z | 2024 | 2 | 2024-02-12T05:00:00Z | 2024-02-12T14:12:23Z | 2024-02741 | 0 | 0 | 09000064864008a6 | |
| FDA-2018-C-4117-0016 | FDA | FDA-2018-C-4117 | Sensient Colors, LLC.; Filing of Color Additive Petition | Rule | Advance Notice of Proposed Rulemaking (ANPRM) | 2024-02-08T05:00:00Z | 2024 | 2 | 2024-02-08T19:40:20Z | 2024-02576 | 0 | 0 | 09000064863f3a4a | ||
| FDA-2021-N-0507-0083 | FDA | FDA-2021-N-0507 | Medical Devices; Quality System Regulation Amendments | Rule | Final Rule | 2024-02-02T05:00:00Z | 2024 | 2 | 2024-02-02T15:49:30Z | 2024-01709 | 0 | 0 | 09000064863d7a7f | ||
| FDA-2023-F-5500-0004 | FDA | FDA-2023-F-5500 | Food Additives Permitted in Feed and Drinking Water of Animals; Chromium Propionate | Rule | Final Rule | 2024-01-30T05:00:00Z | 2024 | 1 | 2024-01-30T05:00:00Z | 2024-03-01T04:59:59Z | 2024-02-07T02:00:36Z | 2024-01796 | 0 | 0 | 09000064863d0736 |
| FDA-2020-C-2131-0008 | FDA | FDA-2020-C-2131 | Listing of Color Additives Exempt From Certification; Jagua (Genipin-Glycine) Blue; Confirmation of Effective Date | Rule | Final Rule | 2024-01-23T05:00:00Z | 2024 | 1 | 2024-01-23T05:00:00Z | 2024-01-23T17:33:50Z | 2024-01106 | 0 | 0 | 09000064863b8838 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);